Disease Information & Support


The Word:


Generic name Pralatrexate
Pronunciation PRAL-a-trek-sate
Brand name(s), other common name(s) Folotyn®
Drug type  Antimetabolite
How the drug is given Intravenously (IV)

Pralatrexate is FDA approved to treat people who have relapsed or refractory peripheral T-cell lymphoma. It is being studied to treat people who have other forms of lymphoma including diffuse large B-cell lymphoma.

Side effects needing medical attention: Mouth sores; tiredness (fatigue); nausea; myelosuppression; infections.


For information on how to manage the costs of drug therapy, please see Financial Matters and Prescription Drug Coverage, or to speak with an Information Specialist, call (800) 955-4572.

last updated on Tuesday, October 16, 2012